Trade Mark Journal No.2025/035 29 August 2025

WO0000001869981 (5)

Office of origin: United States of America

Date of International Registration:23 May 2025
Date of designation in the UK: 23 May 2025
Image for mark 1869981 XOLREMDI

Class 5
Pharmaceutical preparations for the treatment of WHIM syndrome; pharmaceutical preparations for the treatment of immunodeficiencies; pharmaceutical preparations for the treatment of neutropenia.

X4 Pharmaceuticals, Inc.

Representative: Glenn A. Gundersen Dechert LLP, 2929 Arch Street, Cira Centre, Philadelphia PA 19104-2808, UNITED STATES OF AMERICA